2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 255 | 15.643 | 30.789 | 40.485 | 40.702 | 15.216 | 7.881 | 5.432 | 2.420 | 5.034 |
Total Income - EUR | 433 | 16.237 | 31.139 | 40.485 | 40.702 | 15.216 | 7.881 | 5.432 | 2.420 | 5.034 |
Total Expenses - EUR | 1.457 | 22.722 | 35.560 | 38.629 | 46.474 | 16.941 | 6.592 | 1.930 | 1.497 | 1.462 |
Gross Profit/Loss - EUR | -1.024 | -6.485 | -4.421 | 1.856 | -5.773 | -1.725 | 1.290 | 3.502 | 924 | 3.572 |
Net Profit/Loss - EUR | -1.037 | -6.703 | -4.855 | 1.451 | -6.178 | -1.871 | 1.054 | 3.339 | 851 | 3.000 |
Employees | 0 | 2 | 2 | 3 | 4 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Farmamol S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 3.470 | 3.002 | 5.444 | 10.528 | 5.998 | 4.009 | 1.135 | 1.934 | 2.823 | 1.504 |
Inventories | 2.439 | 2.468 | 4.018 | 8.718 | 4.736 | 2.523 | 188 | 751 | 207 | 524 |
Receivables | 222 | 355 | 181 | 291 | 98 | 460 | 0 | 0 | 0 | 22 |
Cash | 809 | 178 | 1.245 | 1.519 | 1.164 | 1.026 | 947 | 1.184 | 2.616 | 959 |
Shareholders Funds | -992 | -7.703 | -12.480 | -10.817 | -16.797 | -18.343 | -16.936 | -13.221 | -12.411 | -9.373 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 4.462 | 10.705 | 17.924 | 21.345 | 22.794 | 22.352 | 18.071 | 15.155 | 15.234 | 10.878 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4743
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmamol S.r.l.